Linde (LIN) net income: $6.9B
Linde reported a net income of $6.9B for the year ended Dec 31, 2025, up 5.1% from $6.6B a year earlier.
From Linde's filings with the SEC · Read the filing · LIN stock page
Linde net income by year
#65 of 3,748 US companies by net income · See the full ranking
| Year ended | Net income | Change |
|---|---|---|
| Dec 31, 2025 | $6.9B | +5% |
| Dec 31, 2024 | $6.6B | +6% |
| Dec 31, 2023 | $6.2B | +49% |
| Dec 31, 2022 | $4.1B | +8% |
| Dec 31, 2021 | $3.8B | – |
Net income of similar companies
Companies in the same industry as Linde, by SEC industry code, with the closest net income. Each name opens the same page for that company.
| Company | Net income, latest year | Year ended |
|---|---|---|
| Gilead Sciences | $8.5B | Dec 31, 2025 |
| Pfizer | $7.8B | Dec 31, 2025 |
| Amgen | $7.7B | Dec 31, 2025 |
| Bristol Myers Squibb | $7.1B | Dec 31, 2025 |
| Linde | $6.9B | Dec 31, 2025 |
| Abbott Laboratories | $6.5B | Dec 31, 2025 |
| Regeneron Pharmaceuticals | $4.5B | Dec 31, 2025 |
Questions and answers
What is Linde's net income?
Linde reported a net income of $6.9B for the year ended Dec 31, 2025, up 5.1% from $6.6B a year earlier.
Numbers as reported in Linde's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology